about
The hepatic apelin system: a new therapeutic target for liver diseaseA prognostic model for predicting survival in cirrhosis with ascites.Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.Lack of a 5.9 kDa peptide C-terminal fragment of fibrinogen α chain precedes fibrosis progression in patients with liver disease.Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis.Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease.Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis.Metastatic Tissue Proteomic Profiling Predicts 5-Year Outcomes in Patients with Colorectal Liver Metastases.Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases.Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis.Akt-mediated foxo1 inhibition is required for liver regeneration.Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis.Letter in reply: Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases.The Role of Akt in Chronic Liver Disease and Liver Regeneration.Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction.Circulating bile is the main factor responsible for atrial natriuretic peptide release in experimental obstructive jaundice.Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis.Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing's syndrome.Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats.Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation.Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis.Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.Pathogenesis of sodium retention in cirrhosis.Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide.Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis.Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosisSerum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility.[Estradiol enhances endothelium-dependent vasodilation via a nitric oxide pathway]Chronology of hemodynamic changes in asymptomatic in vitro fertilization patients and relationship with ovarian steroids and cytokines.Hemodynamic changes induced by urinary human chorionic gonadotropin and recombinant luteinizing hormone used for inducing final follicular maturation and luteinization.Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.Factors involved in extracellular matrix turnover in human derived cardiomyocytes.Sodium retention in cirrhotic rats is associated with increased renal abundance of sodium transporter proteins.Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats.
P50
Q28295197-D378F94B-9421-497F-AC2C-48E3511C7A2BQ32043348-59DAA7B1-7C41-40EF-B4C4-1660169DE491Q33652027-898BA74C-B036-47E9-81DF-7D8CADDA30AFQ33920996-DE14DB04-8621-418C-9369-6423BDEFFBEFQ33986493-EA9B73AB-86CA-4373-8154-501CD26533ADQ34282455-FF734924-DCC3-4128-A498-8D780DC290F4Q35652638-61610B79-7C0E-4DD9-AA47-608F6AC31A8BQ35900706-1529C028-E908-4379-A823-A4C2F5A440B5Q36064692-1E3F868B-0501-47EE-AAD5-F13CE44C0D5BQ36165524-98EB56D1-5B7D-4B12-819A-12B287632699Q36250018-04327E40-CB26-41F3-B8E3-D059BBFB2A2CQ36874818-52CEA26D-D407-4C76-9413-8CE19CDD3AF5Q37220007-4C2FEA3C-5E06-474D-9635-E89BA06A974BQ37525730-D486FB36-F211-4698-B271-A7BAC575444AQ38366999-ED3745E8-C653-4957-A6AA-CA8CB9BF99BEQ38666690-B4B52DD8-727A-4E54-A90E-E479FE1364F2Q39136962-37C5CE8F-4719-4F29-BCEF-87559A782A2CQ39151737-9379DD8C-8BCB-4C39-BC78-2EE15A40D737Q39447799-E6AB84BE-11FE-488B-A5AA-B802FC25FDECQ39596531-BE22D8EF-F043-42F5-A1E6-8CED14E7F8DAQ39711518-0F849E39-27C4-4387-9AC7-77EE02108813Q39732824-3D5EF735-DE88-4BA9-9B8E-47528C5A59B1Q39908420-081FF8D1-C8E5-4D0C-8A63-B73E6FE14567Q39911150-D8225881-06EA-4988-9FCB-29C4D5194FEBQ40068184-8B0FB6BE-BB1C-4A16-8011-9C8AF236D730Q40864067-772811CD-8E5D-411E-A000-DAFC54A6E96AQ41419091-C4ABF030-240B-458E-88FC-DA1A3E8867F6Q42158221-8AE3ADDE-E184-4436-B1F8-2D0321C1EF58Q42487667-9B4BA030-7E6E-431E-95D2-BE2CF5B51075Q42792494-1DA2A821-C378-4686-848F-6F489CBFE95AQ43270171-3704F12B-7307-4D66-BF97-E33BAC48D744Q43561643-0FED289D-B442-4D00-8C22-0230E302B3CAQ43692921-1EFC14FC-98B4-4932-8A9B-50CAD7977243Q44022877-5ED2E631-332F-4913-B318-735338A881B8Q44245856-B1D451D9-3AB2-46BA-8DC9-8E76612E913DQ44451369-2F77A823-BD43-4427-8D1F-3F1C734B71DFQ44632315-5ACA12CF-8B43-4784-845A-C395CDAEC009Q44994063-7F2520B8-27CE-4402-AE01-E9D4780D9882Q45239988-22FFE650-9E55-4BE6-8B5F-03C6C916D001Q45265633-6FDD47FB-EA02-49C6-9780-76C7398D43FF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Wladimiro Jiménez
@ast
Wladimiro Jiménez
@en
Wladimiro Jiménez
@es
Wladimiro Jiménez
@nl
Wladimiro Jiménez
@sl
type
label
Wladimiro Jiménez
@ast
Wladimiro Jiménez
@en
Wladimiro Jiménez
@es
Wladimiro Jiménez
@nl
Wladimiro Jiménez
@sl
prefLabel
Wladimiro Jiménez
@ast
Wladimiro Jiménez
@en
Wladimiro Jiménez
@es
Wladimiro Jiménez
@nl
Wladimiro Jiménez
@sl
P106
P1153
7005147522
P31
P496
0000-0002-9376-0214